Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MNPR-101-DFO*-89Zr
DIAGNOSTIC_TEST
2 trials
Sponsors
Monopar Therapeutics
Conditions
Bladder Cancer
Cancer
Colorectal Cancer
Gastric Cancer
Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Solid Tumor
+3 more
Phase 1
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Active, not recruiting
NCT06337084
Monopar Therapeutics
Bladder Cancer, Colorectal Cancer, Gastric Cancer +6
Start: 2024-05-30
End: 2026-12-01
Target: 12
Updated: 2026-09-03
Unknown Phase
MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer
NCT06980506
Monopar Therapeutics
Cancer, Solid Tumor, Solid Tumor, Adult
Updated: 2026-09-04